Metropolitan Life Insurance Company (MetLife)’s Innospec IOSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,306
| Closed | -$168K | – | 1048 |
|
|
2024
Q1 | $168K | Sell |
1,306
-131
| -9% | -$15.9K | 0.01% | 787 |
|
|
2023
Q4 | $177K | Hold |
1,437
| – | – | 0.01% | 790 |
|
|
2023
Q3 | $147K | Buy |
1,437
+78
| +6% | +$8.15K | 0.01% | 821 |
|
|
2023
Q2 | $136K | Buy |
1,359
+45
| +3% | +$4.51K | 0.01% | 867 |
|
|
2023
Q1 | $135K | Sell |
1,314
-217
| -14% | -$23.4K | 0.01% | 848 |
|
|
2022
Q4 | $157K | Buy |
1,531
+39
| +3% | +$3.96K | 0.01% | 826 |
|
|
2022
Q3 | $128K | Hold |
1,492
| – | – | 0.01% | 877 |
|
|
2022
Q2 | $143K | Hold |
1,492
| – | – | 0.01% | 869 |
|
|
2022
Q1 | $138K | Sell |
1,492
-4,877
| -77% | -$462K | ﹤0.01% | 1001 |
|
|
2021
Q4 | $575K | Sell |
6,369
-496
| -7% | -$43.8K | 0.01% | 1325 |
|
|
2021
Q3 | $578K | Hold |
6,865
| – | – | 0.01% | 1360 |
|
|
2021
Q2 | $622K | Buy |
6,865
+445
| +7% | +$44.1K | 0.01% | 1372 |
|
|
2021
Q1 | $659K | Sell |
6,420
-324
| -5% | -$32.1K | 0.01% | 1243 |
|
|
2020
Q4 | $612K | Sell |
6,744
-655
| -9% | -$50.8K | 0.01% | 1233 |
|
|
2020
Q3 | $469K | Sell |
7,399
-164
| -2% | -$12.2K | 0.01% | 1261 |
|
|
2020
Q2 | $584K | Buy |
7,563
+400
| +6% | +$29.2K | 0.01% | 1084 |
|
|
2020
Q1 | $498K | Sell |
7,163
-370
| -5% | -$33.8K | 0.01% | 1051 |
|
|
2019
Q4 | $779K | Sell |
7,533
-148
| -2% | -$14.2K | 0.01% | 1054 |
|
|
2019
Q3 | $685K | Hold |
7,681
| – | – | 0.01% | 1096 |
|
|
2019
Q2 | $701K | Hold |
7,681
| – | – | 0.01% | 1098 |
|
|
2019
Q1 | $640K | Hold |
7,681
| – | – | 0.01% | 1137 |
|
|
2018
Q4 | $474K | Hold |
7,681
| – | – | 0.01% | 1218 |
|
|
2018
Q3 | $590K | Hold |
7,681
| – | – | 0.01% | 1246 |
|
|
2018
Q2 | $588K | Hold |
7,681
| – | – | 0.01% | 1203 |
|
|
2018
Q1 | $527K | Buy |
7,681
+140
| +2% | +$9.73K | 0.01% | 1237 |
|
|
2017
Q4 | $532K | Sell |
7,541
-8,580
| -53% | -$572K | 0.01% | 1244 |
|
|
2017
Q3 | $994K | Sell |
16,121
-513
| -3% | -$30.7K | 0.01% | 1254 |
|
|
2017
Q2 | $1.09M | Buy |
16,634
+455
| +3% | +$29.2K | 0.01% | 1197 |
|
|
2017
Q1 | $1.05M | Hold |
16,179
| – | – | 0.01% | 1212 |
|
|
2016
Q4 | $1.11M | Sell |
16,179
-415
| -3% | -$26.7K | 0.01% | 1242 |
|
|
2016
Q3 | $1.01M | Hold |
16,594
| – | – | 0.01% | 1280 |
|
|
2016
Q2 | $763K | Hold |
16,594
| – | – | 0.01% | 1421 |
|
|
2016
Q1 | $720K | Hold |
16,594
| – | – | 0.01% | 1353 |
|
|
2015
Q4 | $901K | Hold |
16,594
| – | – | 0.01% | 1238 |
|
|
2015
Q3 | $772K | Sell |
16,594
-1,798
| -10% | -$82.4K | 0.01% | 1331 |
|
|
2015
Q2 | $828K | Sell |
18,392
-957
| -5% | -$42.9K | 0.01% | 1416 |
|
|
2015
Q1 | $898K | Sell |
19,349
-217
| -1% | -$9.31K | 0.01% | 1254 |
|
|
2014
Q4 | $835K | Hold |
19,566
| – | – | 0.01% | 1450 |
|
|
2014
Q3 | $702K | Hold |
19,566
| – | – | 0.01% | 1494 |
|
|
2014
Q2 | $845K | Hold |
19,566
| – | – | 0.01% | 1470 |
|
|
2014
Q1 | $885K | Hold |
19,566
| – | – | 0.01% | 1436 |
|
|
2013
Q4 | $904K | Buy |
19,566
+153
| +0.8% | +$7.02K | 0.01% | 1390 |
|
|
2013
Q3 | $906K | Sell |
19,413
-200
| -1% | -$8.62K | 0.01% | 1336 |
|
|
2013
Q2 | $788K | Buy |
+19,613
| New | +$818K | 0.01% | 1390 |
|
Other funds holding IOSP
WA
RA
Metropolitan Life Insurance Company (MetLife)'s IOSP Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Innospec (IOSP) in Q2 2024, closing a stake of 1,306 shares — an estimated $168K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in IOSP in Q2 2013 and held it in 44 quarters. The position peaked at $1.11M in Q4 2016. 265 funds tracked by Wall St. Rank hold IOSP as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Innospec position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,306 Innospec shares in Q2 2024, an estimated $168K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Innospec in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Innospec position peaked at $1.11M in Q4 2016.
- 265 funds tracked by Wall St. Rank held Innospec as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.